Tag Archives: trends

Energie/Natur/Umwelt Reisen/Tourismus

Nachhaltigkeit-Trends im Tourismus

Gebeco übernimmt Verantwortung und gestaltet eine nachhaltige Reisewelt

Kiel, 22.06.2018. Das Thema Nachhaltigkeit spielt bei der Urlaubsplanung eine immer zentralere Rolle. Die Reiseanalyse der Forschungsgemeinschaft Urlaub und Reisen e.V. verzeichnet seit Jahren ein steigendes Interesse an nachhaltigen Reiseangeboten. Mehr als 60% der Bevölkerung würden ihre Urlaubsreisen gerne nachhaltig gestalten. „Gebeco konzipiert seit jeher Reisen, die verantwortungsvoll mit den Ressourcen und den Menschen vor Ort umgehen“, bestätigt Ury Steinweg, Vorsitzender der Geschäftsführung bei Gebeco. „Auch für die kommende Reisesaison haben wir neue Projekte umgesetzt, mit denen wir unseren Kunden eine nachhaltige Reisewelt bieten können.“ Zu den Nachhaltigkeit-News zählen eine Kooperation mit dem Entwicklungszentrum Rukararwe in Uganda und mehr nachhaltige Elemente bei Volumenreisen.

Weltweites Engagement

Unsere Reisen sollen Brücken bauen; sie sollen helfen, Vorurteile zu reduzieren und das Verständnis für andere Kulturen und Denkweisen fördern“, erklärt Steinweg einen weiteren Aspekt des Nachhaltigkeitsgedanken der Gebeco. „Die enge Zusammenarbeit mit den Partnern vor Ort schafft dabei Begegnung und Verständnis vor allem auch bei der Reiseentwicklung.“ So auch im Fall des Entwicklungszentrums Rukararwe, einem kooperativ geführtem Gemeindeprojekt in Uganda. Zu Besuch im Entwicklungszentrum bekommen Gebeco Reisende Einblicke in das kulturelle, soziale und religiöse Leben sowie in die Natur Südostugandas. Ganz in der Nähe des Zentrums liegen Urwald, Savanne und Hochgebirge, die Heimat vieler seltener Tiere wie dem Berggorilla.

Auch die Gebeco-Hilfsprojekte in Indien und Myanmar leisten ihren Beitrag zu einem nachhaltigen Tourismus. „Das Ziel ist immer, Hilfe zur Selbsthilfe zu leisten und so den Betroffenen eine nachhaltige Perspektive zu geben. Auf diese Weise möchten wir den Einheimischen etwas zurückgeben“, erklärt Steinweg. „Von Gebecos Engagement können sich die Reisenden selbst überzeugen, denn viele Hilfsprojekte können während der Reise besucht werden.“ So weiht eine Gebeco-Reisegruppe Ende Juni zusammen mit ihren Gastgebern ein neues Schulgebäude für die Amaka Primary School in Myanmar am Inle See ein. Mit dem Bau unterstützt Gebeco die Dorfschule

an der 52 muslimische und buddhistische Schüler zwischen fünf und zehn Jahren gemeinsam lernen und spielen. „Nachhaltigkeit funktioniert nur, wenn alle am Tourismus Beteiligten kooperieren“, gibt Steinweg zu bedenken. „Sämtliche Touristikunternehmen stehen vor der großen Herausforderung, die Einhaltung der allgemeinen Menschenrechte bei ihren internationalen Partnern und generell vor Ort zu forcieren und Missstände aufzudecken.“ Gebeco engagiert sich daher auch im Roundtable für Menschenrechte und stellt sich bei den anstehenden Neuwahlen des Vorstands erneut zur Verfügung.

Nachhaltiges Reisen

Einen weltweiten Tourismus und den Schutz der Atmosphäre zu vereinbaren, ist eine große Herausforderung. Gebeco trägt im Rahmen der Nachhaltigkeitsstrategie der TUI Group seinen Teil bei: Wo möglich mit Direktflügen modernster Maschinen, der Unterbringung in sorgfältig ausgewählten Hotels und der Unterstützung von Klimaschutzprojekten. „Bei der Planung unserer Reiseprogramme achten wir darauf, unnötige Busfahrten und Inlandsflüge zu vermeiden“, erklärt Steinweg. Die Kunden haben die Möglichkeit, ihren Anteil an den Flug-Emissionen ihrer Reise zu kompensieren und so ihren Beitrag zum Klimaschutz zu leisten. Gebeco geht mit gutem Beispiel voran und kompensiert alle Dienstreisen der eigenen Mitarbeiter.„Besonders freut es uns, dass wir dank unserer hauseigenen Photovoltaikanlage in den letzten 12 Monaten 45 t CO2 einsparen konnten“, fügt Steinweg hinzu. Wir produzieren ca. 30 % unseres Stroms selbst. Bei dem zugekauften Strom handelt es sich um Öko-Strom.“ Auch für die neue Reisesaison bleibt der Nachhaltigkeitsgedanke federführend. „Wir werden die nachhaltigen Elemente auch in unseren Volumenreisen weiter ausbauen“, fügt Steinweg hinzu.

Natürlich Sri Lanka!“, Gebeco Länder erleben

15-Tage-Erlebnisreise ab 2.455 € inkl. Flüge

Link zur Reise: www.gebeco.de/2750011

Termine: 29.09.-13.10.2018, 13.10.-27.10.2018, 02.02.-16.02.2019, 16.02.-02.03.2019, 16.03.-30.03.2019

Vormerktermine 2019: 28.09.-12.10., 12.10.-26.10., 02.11.-16.11.2019

Weitere nachhaltige Reisen unter: www.gebeco.de/reisen/nachhaltig

Gebeco (Gesellschaft für internationale Begegnung und Cooperation) ist mit jährlich rund 60.000 Gästen und 116 Mio. Euro Umsatz einer der führenden Veranstalter von Studien- und Erlebnisreisen im deutschsprachigen Raum. Im Portfolio: weltweite Erlebnisreisen, Dr. Tigges Studienreisen, Privatreisen, Aktivreisen, Erlebnis-Kreuzfahrten, Abenteuerreisen mit goXplore u.v.m. Authentische Begegnungen mit fremden Menschen und Kulturen stehen im Mittelpunkt. Gebeco engagiert sich für einen nachhaltigen Tourismus und trägt seit 2011 das Nachhaltigkeits-Siegel „CSR-Tourism-certified“.

Kontakt für Presse- und Bildanfragen

Pressestelle Gebeco

Tel.: +49 (0) 431 5446-230

E-Mail: presse@gebeco.de

Kontakt für Reisebüros und Kunden

Gebeco Service Center

Tel. +49 (0) 431 5446-0

E-Mail: kontakt@gebeco.de

Pressemitteilungen

Bildung in Deutschland 2018: Bericht zu Trends und Herausforderungen von Kita bis Weiterbildung

Schwerpunktthema Wirkungen und Erträge von Bildung

Bildung in Deutschland 2018: Bericht zu Trends und Herausforderungen von Kita bis Weiterbildung

Hoher Fachkräftebedarf in Kitas, Trend zu höherer Schulbildung, sinkende Ausbildungsquote, große Studiennachfrage, aber viele Studienabbrecher und viele Teilnehmer in der betrieblichen Weiterbildung: Der Bericht „Bildung in Deutschland 2018“ zeigt das deutsche Bildungssystem in seiner ganzen Dynamik.

Zum 7. Mal führt „Bildung in Deutschland“ Daten aus allen Bildungsbereichen Deutschlands zusammen und wertet sie systematisch aus, von Kita bis Hochschule und Weiterbildung. Im Mittelpunkt steht der Gesamtzusammenhang von Bildung im Lebenslauf, im Unterschied zu bereichsspezifischen Einzelberichten. Die Auswertungen machen übergreifende Trends und Problemlagen sichtbar und zeichnen zugleich ein detailliertes Bild der Entwicklungen in unterschiedlichen Bereichen.

Die Ergebnisse des Schwerpunktthemas „Wirkungen und Erträge von Bildung“ zeigen, dass sich Bildung für die Menschen und auch für den Staat lohnt. Ein steigender Bildungsstand wirkt sich positiv auf Arbeitsmarktintegration, Verdienst, politisches und ehrenamtliches Engagement und Gesundheit aus. Auch zu Müttererwerbstätigkeit,
„gender pay gap“, Lebenszufriedenheit und Kompetenzentwicklung durch Kitas liefern die Beiträge zum Schwerpunktthema interessante Erkenntnisse.

„Bildung in Deutschland 2018“ ist eine wichtige Informationsquelle für Bildungspolitik, -verwaltung und -praxis, für die Öffentlichkeit sowie für Wissenschaft und Forschung. Der vollständige Bericht sowie die dazugehörige Kurzfassung können kostenfrei bei wbv-open-access.de heruntergeladen werden.

Die gedruckte Ausgabe ist im Buchhandel oder bei wbv.de erhältlich. Auf der Website bildungsbericht.de stellt die Autorengruppe Informationen zur Konzeption des Berichtes sowie Daten zum Bericht zur Verfügung.

– Autoren –
Verantwortlich für „Bildung in Deutschland 2018“ ist die Autorengruppe Bildungsberichterstattung, deren Mitglieder unterschiedliche wissenschaftliche Einrichtungen und statistische Ämter vertreten. Die Federführung des Berichts liegt beim Deutschen Institut für Internationale Pädagogische Forschung (DIPF).

Zur Autorengruppe gehören Prof. Dr. Kai Maaz (DIPF), Prof. Dr. Martin Baethge (SOFI), Leitende Regierungsdirektorin Pia Brugger (Destatis), Prof. Dr. Thomas Rauschenbach (DJI), Prof. Dr. Ulrike Rockmann (StLÄ), Prof. Dr. Susan Seeber (SOFI/Universität Göttingen), Prof. Dr. Andrä Wolter (HU Berlin/DZHW), Dr. Stefan Kühne (DIPF).

Die Erarbeitung des Berichts wurde von der Ständigen Konferenz der Kultusminister der Länder der Bundesrepublik Deutschland und vom Bundesministerium für Bildung und Forschung gefördert.

————————————–

Autorengruppe Bildungsberichterstattung
– Bildung in Deutschland 2018 –
Ein indikatorengestützter Bericht mit einer Analyse zu Wirkungen und Erträgen von Bildung
wbv Media, Bielefeld 2018, 374 Seiten

Druckausgabe:
Bestell-Nr. 6001820f
ISBN 978-3-7639-5964-8
69,00 Euro

Kostenfreie digitale Ausgabe:
DOI 10.3278/6001820fw

wbv Media ist ein Medien- und Logistikunternehmen mit drei Geschäftsbereichen: wbv Publikation, wbv Kommunikation und wbv Distribution.

wbv Publikation verlegt Wissenschafts- und Fachliteratur zu den Themenfeldern Sozialwissenschaften und Sozialforschung, Bildung und Beruf sowie Verwaltung und Recht. wbv Kommunikation begleitet öffentliche Auftraggeber:innen, Körperschaften, Verbände und Vereinigungen bei der Kommunikationsarbeit, von der strategischen Beratung bis zur Umsetzung. wbv Distribution bietet Lösungen für die Bereitstellung und Versendung von Medienprodukten und kombiniert Standards mit individuellen Zusatzleistungen.

Über 60 Mitarbeiter:innen setzen die Medien- und Logistikprojekte um.

Das Unternehmen mit Sitz in Bielefeld-Dornberg wurde 1864 gegründet und feierte 2014 sein 150jähriges Bestehen. Am 1. März 2018 änderte das Unternehmen seinen Namen von W. Bertelsmann Verlag (wbv) in wbv Media.

Firmenkontakt
wbv Media
Klaudia Künnemann
Auf dem Esch 4
33619 Bielefeld
0521 / 91101-10
service@wbv.de
http://www.wbv.de

Pressekontakt
wbv Media
Klaudia Künnemann
Auf dem Esch 4
33619 Bielefeld
0521 / 91101-21
0521 / 91101-79
presse@wbv.de
http://www.wbv.de/presse

Gesundheit/Medizin

Retinol Serum mit Hyaluron – Das Anti-Aging Serum für Gesicht und Haut

Für hohe Ansprüche an eine effektive und verträgliche Hautpflege bietet Casida das hochwertige Retinol Serum mit Hyaluron.

Das im Retinol Serum mit Hyaluron enthaltene Vitamin A (Retinol) ist eine der wirksamsten Anti-Aging-Substanzen. Es kann die Zellerneuerung anregen, den altersbedingten Zellabbau stoppen, das Bindegewebe stärken und die Faltentiefe verringern. Retinol unterstützt die Haut, Feuchtigkeit im Zwischenzellgewebe zu ersetzen und zu bewahren. Zusätzlich verbessert es die Sauerstoffzufuhr zu den Zellen bis in tiefere Hautschichten, wirkt oxidativem Stress und damit dem Alterungsprozess entgegen. Die Haut kann regenerieren und hat so optimale Bedingungen für eine verbesserte Hautelastizität und eine geglättete Struktur mit mehr Volumen.

Die ebenfalls im Retinol Serum mit Hyaluron enthaltenen Vitamine C und E schützen die Zellen vor freien Radikalen, fördern die Kollagenbildung, binden Feuchtigkeit und reduzieren in Kombination mit der hautverjüngenden Hyaluronsäure den Feuchtigkeitsverlust. Durch das Serum von Casida wird die Haut geschmeidig, der Teint ebenmäßig und strahlend.

Das Retinol Serum mit Hyaluron mit seiner flüssigen Konsistenz zieht ohne Rückstände schnell ein und hinterlässt ein sehr angenehmes Hautgefühl.

Das hochwertige Anti-Aging Retinol Serum mit Hyaluron ist für einen optimalen Oxidationsschutz im praktischen Pumpspender erhältlich. Die hochwertige Violettglasflasche schützt das wertvolle Serum vor Lichteinwirkung. Die Anwendung ist einfach und sparsam.

Das Serum ist frei von Silikonen, Farbstoffen, Parabenen und Mineralölen.

Entdecken Sie jetzt die neuen Beauty Produkte von Casida und bleiben Sie natürlich schön.
Exklusiv in Apothekenqualität. Erhältlich in allen Apotheken, bei pharmazeutischen Großhändlern oder direkt bei Casida.

Retinol Serum mit Hyaluron

Inhalt: 30 ml
PZN: 14044047

Bildquelle: Casida GmbH & Co KG

Casida GmbH & Co. KG

August-Bebel-Str. 43

08412 Werdau

Telefon: + 49 (0) 3761 – 7608015

Telefax: +49 (0) 3761 – 3669987

Web: www.casida.de

E-Mail: info@casida.de

Aktuelle Nachrichten Gesundheit/Medizin Marketing/Werbung Mode/Lifestyle

Global Phototherapy Equipment Market Size, Dynamics, Regional Share, Trends, Competitor Analysis 2013-2017 and Forecast 2018-2024

Global Phototherapy Equipment Market: By Device Type (Fluorescent Lamps, Compact Fluorescent Lamps, Fiberoptic Phototherapy Equipment, LED Phototherapy Equipment, and Conventional Phototherapy Equipment), By Application (Neonatal Jaundice and Skin Diseases), By End User (Hospitals, Clinics, and Others), and Geography – Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2013-2017 and Forecast 2018-2024

 

Global phototherapy equipment market was valued at US$ XX Mn in 2017 and expected to grow at XX% Compound Annual Growth Rate (CAGR) from 2018 to 2024

Market Outline: Phototherapy Equipment Market

Phototherapy or light therapy involves exposing the skin to ultraviolet light on a regular basis and under medical supervision. The UV part of the radiation emitted by the sun that is used in phototherapy, especially the ultraviolet B (UVB) and ultraviolet A (UVA) wavelengths. Using phototherapy, exposure of specific wavelengths of light using polychromatic polarized light, fluorescent lamps, and lasers is used for the treatment.

 

Market Dynamics: Phototherapy Equipment Market

Increase in the prevalence of neonatal jaundice and growing number of the preterm birth are the key factors attributed for the growth of the phototherapy equipment market. According to the National Center for Biotechnology Information (NCBI), around 13 million babies are affected with jaundice all across the globe. The increasing incidence of the psoriasis is aiding the growth of the phototherapy equipment market. According to the International Federation of Psoriasis Associations (IFPA), around 150,000 new cases are reported in the U.S every year and 3% of people are affected by some form of psoriasis around the world. The treatment of these skin disorders requires phototherapy, which is expected to boost the growth of the market. However, the high cost of the equipment may hinder the growth of the phototherapy equipment market.

 

Free sample of this report is available upon request @

https://www.precisionbusinessinsights.com/market-reports/phototherapy-equipment-market/#ulp-4H8Z4LpNMLEuOnnx

 

Market Scope: Phototherapy Equipment Market

Phototherapy equipment market is segmented based on the device type, application, and distribution channel

Based on the device type, the market is segmented into the following:

  • Fluorescent Lamps
  • Compact Fluorescent Lamps
  • Fiberoptic Phototherapy Equipment
  • LED Phototherapy Equipment
  • Conventional Phototherapy Equipment

Based on the application, the market is segmented into the following:

  • Neonatal Jaundice
  • Skin Diseases
    • Psoriasis
    • Eczema
    • Other skin diseases
  • Others

Based on the distribution channel, the market is segmented into the following:

  • Hospitals
  • Clinics
  • Others

 

Free TOC of this report is available upon request @

https://www.precisionbusinessinsights.com/market-reports/phototherapy-equipment-market/#ulp-c654SbFYO64MsOhu

 

Regional Analysis:  Phototherapy Equipment Market

Geographically, global phototherapy equipment market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. North America phototherapy equipment market to keep top spot in the global phototherapy equipment market. The rising awareness among the people regarding the modern treatment procedures for treating skin-related disorders is enhancing the growth of the phototherapy equipment market. For instance, according to the American Academy of Dermatology acne is the most common skin condition in the U.S., affecting around 50 million people in the country each year. Europe and Asia Pacific phototherapy equipment market is expected to grow exponentially over the forecast period.

 

Ask Analyst for Full Information about this report @

https://www.precisionbusinessinsights.com/market-reports/phototherapy-equipment-market/#ulp-14mlyhjMGhVjZqa3

 

Competition Assessment: Phototherapy Equipment Market

Some of the players in the global phototherapy equipment market include:

  • Atom Medical Corporation (Japan)
  • National Biological Corp. (U.S.)
  • Solarc Systems Inc. (Canada)
  • GE Healthcare (U.K.)
  • Philips Lighting Holding B.V. (Netherlands
  • Natus Medical Incorporated (U.S.)
  • Phoenix Medical Systems Pvt. Ltd. (India)
  • Herbert Waldmann GmbH & Co. KG (Germany)

 

Get access to full summary @

https://www.precisionbusinessinsights.com/market-reports/phototherapy-equipment-market/

 

About Precision Business Insights

Precision Business Insights is one of the leading market research and business consulting firm, which follow a holistic approach to solve needs of the clients. We adopt and implement proven research methodologies to achieve better results. We help our clients by providing actionable insights and strategies to make better decisions. We provide consulting, syndicated and customised market research services based on our client needs.

Contact to Precision Business Insights,

Kemp House,

152 – 160 City Road,

London EC1V 2NX

Email: sales@precisionbusinessinsights.com

Toll Free (US):+1-866-598-1553

Website @https://www.precisionbusinessinsights.com

Aktuelle Nachrichten Finanzen/Wirtschaft Gesundheit/Medizin Internationales Marketing/Werbung Pressemitteilungen

Global Thrombocytopenia Treatment Market Size, Dynamics, Regional Share, Trends, Competitor Analysis 2013-2017 and Forecast 2018-2024

Global Thrombocytopenia Treatment Market: By Drug Class (Lysosomal Enzyme, Platelet Stimulating Agents, and Glucocorticoids), By Disease Indication (Leukemia, Hemolytic Uremic Syndrome, Immune Thrombocytopenia, and Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and Geography – Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2013-2017 and Forecast 2018-2024

 

Global thrombocytopenia treatment market was valued at US$ XX Mn in 2017 and expected to grow at XX% Compound Annual Growth Rate (CAGR) from 2018 to 2024

 

Market Outline: Thrombocytopenia Treatment Market

Thrombocytopenia is the condition where in which the patient has a low platelet count. The root cause for the thrombocytopenia are the platelet splenic sequestration, inefficiency in the production of the platelets and the destruction of the platelets. Thrombocytopenia is either inherited or acquired. It usually occurs owing to various disorders such as leukemia and immune system related conditions. This is commonly found in both adults and children. In thrombocytopenia condition show very less symptoms and is mild. In some cases, the count of the platelets is so low that it causes dangerous internal bleeding, as the patient affected with the thrombocytopenia leads to delayed blood clotting or sometimes no blood clotting.

 

Market Dynamics: Thrombocytopenia Treatment Market

Increase in the prevalence of thrombocytopenia all across the globe and rising count of the chronic hepatitis C cases, which causes the risk of thrombocytopenia are likely to drive the growth of the market. The growing government support by financial aids to the patients in developing and under developed countries expected to drive the market revenue growth over forecast period. However, the stringent government regulations for approvals of newer treatments and increasing introduction of the generic drugs may hinder the growth of the market.

 

Free sample of this report is available upon request @

https://www.precisionbusinessinsights.com/market-reports/thrombocytopenia-treatment-market/#ulp-4H8Z4LpNMLEuOnnx

 

Market Scope: Thrombocytopenia Treatment Market

Thrombocytopenia treatment market is segmented based on the drug class, disease indication, and distribution channel

 

Based on the drug class, the market is segmented into the following:

  • Lysosomal Enzyme
  • Platelet Stimulating Agent
  • Glucocorticoids

Based on the disease indication, the market is segmented into the following:

  • Leukemia
  • Hemolytic Uremic Syndrome
  • Immune Thrombocytopenia
  • Others

Based on the distribution channel, the market is segmented into the following:

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

 

Free TOC of this report is available upon request @

https://www.precisionbusinessinsights.com/market-reports/thrombocytopenia-treatment-market/#ulp-c654SbFYO64MsOhu

 

Regional Analysis:  Thrombocytopenia Treatment Market

Geographically, global thrombocytopenia treatment market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. North America thrombocytopenia treatment market is growing due to increase in the prevalence of thrombocytopenia. The deep-rooted healthcare infrastructure is also anticipated to drive the growth of the market in the region. The awareness among the patient population regarding the new treatment methods is likely to enhance the growth of the market in the region. The adoption of the new treatment procedures by the patient pool is boosting the growth of the thrombocytopenia treatment market in the region.

 

Competition Assessment: Thrombocytopenia Treatment Market

Some of the players in the global thrombocytopenia treatment market include:

  • Merck & Co., Inc. (U.S)
  • Bristol-Myers Squibb Company (U.S)
  • ViroMed Co., Ltd (South Korea)
  • Rigel Pharmaceuticals, Inc. (U.S)
  • Shionogi & Co., Ltd. (Japan)
  • Cellerant Therapeutics, Inc. (U.S)

 

Ask Analyst for Full Information about this report @

https://www.precisionbusinessinsights.com/market-reports/thrombocytopenia-treatment-market/#ulp-14mlyhjMGhVjZqa3

 

Notable Market Developments: Thrombocytopenia Treatment Market

  • In February 2018, Shionogi & Co., Ltd announced that the New Drug Application (NDA) for lusutrombopag (S-888711), an investigational, once-daily, orally administered, small molecule thrombopoietin (TPO) receptor agonist, has been accepted for filing and has been granted Priority Review by the U.S. Food & Drug Administration (FDA)

 

 

Get access to full summary @

https://www.precisionbusinessinsights.com/market-reports/thrombocytopenia-treatment-market/

 

About Precision Business Insights

Precision Business Insights is one of the leading market research and business consulting firm, which follow a holistic approach to solve needs of the clients. We adopt and implement proven research methodologies to achieve better results. We help our clients by providing actionable insights and strategies to make better decisions. We provide consulting, syndicated and customised market research services based on our client needs.

Contact to Precision Business Insights,

Kemp House,

152 – 160 City Road,

London EC1V 2NX

Email: sales@precisionbusinessinsights.com

Toll Free (US):+1-866-598-1553

Website @https://www.precisionbusinessinsights.com

 

Aktuelle Nachrichten Gesundheit/Medizin Internationales Marketing/Werbung Medien/Entertainment Pressemitteilungen Wissenschaft/Forschung

Tissue Engineered Collagen Biomaterials Market Size, Dynamics, Regional Share, Trends, Competitor Analysis 2013-2017 and Forecast 2018-2024

Global Tissue Engineered Collagen Biomaterials Market: By Source (Marine, Bovine, Chicken, Porcine, and Others), By Application (Wound Care, Orthopedic, and Others), By Distribution Channel (Hospitals, Orthopedic Clinics, and Others), and Geography – Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2013-2017 and Forecast 2018-2024

 

Global tissue Engineered collagen biomaterials market was valued at US$ XX Mn in 2017 and expected to grow at XX% Compound Annual Growth Rate (CAGR) from 2018 to 2024

 

Market Outline: Tissue Engineered Collagen Biomaterials Market

Collagen is the class of protein that is widely distributed in the human body. The collagen-based biomaterials has been used intensively in the tissue engineering applications. There are various methods such as multiple-cross linking and several combinations of biopolymers are being investigated, which further helps in improving the tissue function.

Increase in the use of collagen as the bone substitutes is the key factor attributed for the growth of the market. The growing initial investments in the research and development activities and rising use of the collagen in the wound healing process is enhancing the growth of the market. However, stringent government regulations are likely to hamper the growth of the market.

 

Free sample of this report is available upon request @

https://www.precisionbusinessinsights.com/market-reports/tissue-engineered-collagen-biomaterials-market/#ulp-4H8Z4LpNMLEuOnnx

 

Market Scope: Tissue Engineered Collagen Biomaterials Market

Tissue Engineered collagen biomaterials market is segmented based on the source, applications, and distribution channel

Based on the source, the market is segmented into the following:

  • Marine
  • Bovine
  • Chicken
  • Porcine
  • Others

Based on the application, the market is segmented into the following:

  • Wound Care
  • Orthopedic
  • Others

Based on the distribution channel, the market is segmented into the following:

  • Hospitals
  • Orthopedic Clinics
  • Others

 

Free TOC of this report is available upon request @

https://www.precisionbusinessinsights.com/market-reports/tissue-engineered-collagen-biomaterials-market/#ulp-c654SbFYO64MsOhu

 

Regional Analysis:  Tissue Engineered Collagen Biomaterials Market

Geographically, global tissue engineered collagen biomaterials market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. North America tissue Engineered collagen biomaterials market holds dominant share when compared with that of the other regional markets. The soaring use of the collagen in numerous orthopedic applications is anticipated to drive the growth of the market in the region. The European region and the Asia Pacific follow the suit. The Asia Pacific is expected to show significant growth over the forecast period owing to its burgeoning ageing population. The increasing prevalence of chronic diseases is another factor attributed for the growth of the market in the region.

 

Ask Analyst for Full Information about this report @

https://www.precisionbusinessinsights.com/market-reports/tissue-engineered-collagen-biomaterials-market/#ulp-14mlyhjMGhVjZqa3

 

Competition Assessment: Tissue Engineered Collagen Biomaterials Market

Some of the players in the global tissue Engineered collagen biomaterials market include:

  • Medtronic (U.S)
  • Collagen Solutions Plc (UK)
  • Kyeron B.V (The Netherlands)
  • Collagen Matrix Inc (U.S)
  • Fraunhofer-Gesellschaft (Germany)
  • Maxigen Biotech Inc (Taiwan)
  • Advanced BioMatrix Inc (U.S)

 

Notable Market Developments: Tissue Engineered Collagen Biomaterials Market

  • In July 2017, Collagen Solutions plc has announced its first patient enrolment in ChondroMimetic long-term clinical study.

 

Get access to full summary @

https://www.precisionbusinessinsights.com/market-reports/tissue-engineered-collagen-biomaterials-market/

 

About Precision Business Insights

Precision Business Insights is one of the leading market research and business consulting firm, which follow a holistic approach to solve needs of the clients. We adopt and implement proven research methodologies to achieve better results. We help our clients by providing actionable insights and strategies to make better decisions. We provide consulting, syndicated and customised market research services based on our client needs.

Contact to Precision Business Insights,

Kemp House,

152 – 160 City Road,

London EC1V 2NX

Email: sales@precisionbusinessinsights.com

Toll Free (US):+1-866-598-1553

Website @https://www.precisionbusinessinsights.com

 

Aktuelle Nachrichten Finanzen/Wirtschaft Gesundheit/Medizin Internationales Marketing/Werbung

Global Uveal Melanoma Therapeutics Market Size, Dynamics, Regional Share, Trends, Competitor Analysis 2013-2017 and Forecast 2018-2024

Global Uveal Melanoma Therapeutics Market: By Disease Type (Choroidal Melanomas, Iris Melanomas, and Ciliary Body Melanomas), By Treatment Type (Chemotherapy, Immunotherapy, and Targeted Therapy), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and Geography – Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2013-2017 and Forecast 2018-2024

 

Global uveal melanoma therapeutics market was valued at US$ XX Mn in 2017 and expected to grow at XX% Compound Annual Growth Rate (CAGR) from 2018 to 2024

 

Market Outline: Uveal Melanoma Therapeutics Market

Uveal melanoma is a disease in which malignant (cancer) cells form in the tissues of the eye. The tumors arise from the melanocytes that reside within the uvea giving color to the eye. Uveal melanoma begins between the three layers of the wall of the eye. The first layer (outer layer) includes sclera and the cornea at the front of the eye. The inner layer has a retina, that senses light and send images. The middle layer is the layer in which the melanoma forms. This layer is called as uvea.

Increase in the prevalence of uveal melanoma is driving the growth of the market. The rising awareness among the people regarding the disease among healthcare fraternity is anticipated to drive the growth of the uveal melanoma therapeutics market. However, the higher cost of the therapy and reimbursement policies are may constrain the growth of the market.

 

Free sample of this report is available upon request @

https://www.precisionbusinessinsights.com/market-reports/uveal-melanoma-therapeutics-market/#ulp-4H8Z4LpNMLEuOnnx

 

Market Scope: Uveal Melanoma Therapeutics Market

Uveal melanoma therapeutics market is segmented based on the disease type, treatment type, and distribution channel.

Based on the disease type, the market is segmented into the following:

  • Choroidal Melanomas
    • Small Melanomas
    • Medium-sized Melanomas
    • Large Melanomas
  • Iris melanomas
  • Ciliary Body Melanomas

Based on the treatment type, the market is segmented into the following:

  • Chemotherapy
    • Methotrexate
    • Others
  • Immunotherapy Drugs
    • Pembrolizumab
    • Ipilimumab
    • Others
  • Targeted Drugs

Based on the distribution channel, the market is segmented into the following:

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

 

Free TOC of this report is available upon request @

https://www.precisionbusinessinsights.com/market-reports/uveal-melanoma-therapeutics-market/#ulp-c654SbFYO64MsOhu

 

Regional Analysis:  Uveal Melanoma Therapeutics Market

Geographically, global uveal melanoma therapeutics market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. North America uveal melanoma therapeutics market is driven by increase in the prevalence of the eye related disorders. The growing patient population with uveal melanoma disorder expected fuel the market growth in the region. According to the American Cancer Society, about nine of 10 melanomas of the eye develop in the choroid. It also states that 2,730 new cases were detected in 2014 of uveal melanoma in the U.S.

 

Competition Assessment: Uveal Melanoma Therapeutics Market

Some of the players in the global uveal melanoma therapeutics market include:

  • Eli Lilly & Co. (U.S)
  • Novartis AG (Switzerland)
  • AstraZeneca plc (UK)
  • Pfizer, Inc. (U.S)
  • Merck (U.S)
  • Roche (Switzerland)
  • Amgen (U.S)
  • Bayer (Germany)
  • Spectrum Pharmaceuticals, Inc. (U.S)

 

Ask Analyst for Full Information about this report @

https://www.precisionbusinessinsights.com/market-reports/uveal-melanoma-therapeutics-market/#ulp-14mlyhjMGhVjZqa3

 

Notable Market Developments: Uveal Melanoma Therapeutics Market

  • Bristol-Myers Squibb and National Cancer Institute (NCI) completed the phase II study of Nivolumab in combination with Ipilimumab for Uveal Melanoma

 

Get access to full summary @

https://www.precisionbusinessinsights.com/market-reports/uveal-melanoma-therapeutics-market/

 

About Precision Business Insights

Precision Business Insights is one of the leading market research and business consulting firm, which follow a holistic approach to solve needs of the clients. We adopt and implement proven research methodologies to achieve better results. We help our clients by providing actionable insights and strategies to make better decisions. We provide consulting, syndicated and customised market research services based on our client needs.

Contact to Precision Business Insights,

Kemp House,

152 – 160 City Road,

London EC1V 2NX

Email: sales@precisionbusinessinsights.com

Toll Free (US):+1-866-598-1553

Website @https://www.precisionbusinessinsights.com

 

Aktuelle Nachrichten Gesundheit/Medizin Internationales Marketing/Werbung Pressemitteilungen

Global Vagus Nerve Stimulation (VNS) Devices Market Size, Dynamics, Regional Share, Trends, Competitor Analysis 2013-2017 and Forecast 2018-2024

Global Vague Nerve Stimulation (VNS) Devices Market: Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2013-2017 and Forecast 2018-2024

 

Global Vague Nerve Stimulation (VNS) Devices Market: By Product Type ( Implantable VNS Devices and External VNS Devices ), By Application ( Depression, Epilepsy, and Migraine ), By End User ( Hospitals, Ambulatory Surgical Centers (ASCS), and Others) , and Geography – Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2013-2017 and Forecast 2018-2024

 

Global Vague Nerve Stimulation (VNS) devices market valued at US $ XX Mn in 2017 and is expected to grow at XX% Compound Annual Growth Rate (CAGR) from 2018 to 2024

 

Market Outline: Vagus Nerve Stimulation (VNS) Devices Market

Vagus nerve stimulation process involves implantation of a device that stimulates the vagus nerve with electrical impulses. The vagus nerves are a pair of nerves that start in the brain and run through the body. This is a nervous play in the conversation between the brain and the body. The vagus nerve stimulation is most often used to treat epilepsy. Vagus nerve stimulation devices are designed to prevent seizures by sending regular, mild pulses of electrical energy to the brain via the vagus nerve. Vagus nerve stimulation device is sometimes referred to as a „pacemaker for the brain.“ The device is placed under the skin on the chest and a wire runs from it to the vagus nerve in the neck.

 

Market Dynamics: Vagus Nerve Stimulation (VNS) Devices Market

According to the WHO, 4.5% -11% of all illnesses. The increasing prevalence of neurological disorders such as migraine and epilepsy among all age groups is expected to drive the market revenue growth. The increasing R & D activities, favorable reimbursement policies are expected to fuel the growth of the Vagus Nerve Stimulation (VNS) devices market. However, the higher treatment costs may be the growth of the market. According to the Epilepsy Foundation, VNS therapy currently costs approximately $ 30,000.

 

Free sample of this report is available upon request @

https://www.precisionbusinessinsights.com/market-reports/vagus-nerve-stimulation-vns-devices-market/#ulp-4H8Z4LpNMLEuOnnx

 

Market Scope: Vagus Nerve Stimulation (VNS) Devices Market

Vagus Nerve Stimulation (VNS) devices market is segmented based on the product type, by application, and end user

Based on the product type, the market is segmented into the following:

  • Implantable VNS Devices
  • External VNS Devices

Based on the application, the market is segmented into the following:

  • Depression
  • Epilepsy
  • Migraine

Based on the end user, the market is segmented into the following:

  • Hospitals
  • Ambulatory Surgical Centers (ASCs)
  • Others

 

Free TOC of this report is available upon request @

https://www.precisionbusinessinsights.com/market-reports/vagus-nerve-stimulation-vns-devices-market/#ulp-c654SbFYO64MsOhu

 

Regional Analysis:  Vagus Nerve Stimulation (VNS) Devices Market

Geographically, global vagus nerve stimulation (VNS) devices market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. North America Vagus nerve stimulation (VNS) devices market is the fastest growing region. The increasing prevalence of the neurological disorders and the rise in the adoption of the VNS devices for the treatment of various neurological disorders expected to add fuel the market revenue growth. European market stands next to the North America market. Asia Pacific is the region expected to offer lucrative opportunities owing to rapid development in healthcare technology with a huge patient pool.

 

Ask Analyst for Full Information about this report @

https://www.precisionbusinessinsights.com/market-reports/vagus-nerve-stimulation-vns-devices-market/#ulp-14mlyhjMGhVjZqa3

 

Competition Assessment: Vagus Nerve Stimulation (VNS) Devices Market

Some of the players in the global vagus nerve stimulation (VNS) devices market include:

  • LivaNova PLC (UK)
  • EnteroMedics Inc. (US)
  • ElectroCore Medical LLC (US)
  • Boston Scientific Corporation (US)
  • Cyberonics, Inc. (US)
  • NeuroMetrix, Inc.(US)
  • ImThera Medical (US)
  • Inspire Medical Systems, Inc.(US)

 

Notable Market Developments: Vagus Nerve Stimulation (VNS) Devices Market

  • In October 2017, LivaNova PLC (NASDAQ:LIVN) (“LivaNova” or the “Company”), a market-leading medical technology company, received U.S. Food and Drug Administration (“FDA”) approvals for its latest Vagus Nerve Stimulation Therapy (“VNS Therapy”) System, which consists of the SenTiv implantable generator and the next-generation VNS Therapy Programming System for the treatment of patients with drug-resistant epilepsy.

 

Get access to full summary @

https://www.precisionbusinessinsights.com/market-reports/vagus-nerve-stimulation-vns-devices-market/

 

About Precision Business Insights

Precision Business Insights is one of the leading market research and business consulting firms, which follows a holistic approach to solve the needs of the clients. We adopt and implement proven research methodologies to achieve better results. We help our clients by providing actionable insights and making better decisions. We provide consulting, syndicated and customized market research services based on our client needs.

Contact to Precision Business Insights,

Kemp House,

152 – 160 City Road,

London EC1V 2NX

Email: sales@precisionbusinessinsights.com

Toll Free (US): 1-866-598-1553

Website @ https://www.precisionbusinessinsights.com

 

Aktuelle Nachrichten Gesundheit/Medizin Internationales Marketing/Werbung Pressemitteilungen

Global Vitrectomy Machines Market Size, Dynamics, Regional Share, Trends, Competitor Analysis 2013-2017 and Forecast 2018-2024

Global Vitrectomy Machines Market: By Product Type (Vitrectomy Machines, Vitrectomy Packs, Microscopic Illumination Equipment, Surgical Instruments, and Others), By Application (Retinal Detachment, Diabetic Retinopathy, Trauma, Macular Surgery, Pediatric Retinal Disorders, and Others), By End Users (Hospitals, Eye Clinics, and Others), and Geography – Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2013-2017 and Forecast 2018-2024

 

Global vitrectomy machines was valued at US $ XX Mn in 2017 and is expected to grow at XX% Compound Annual Growth Rate (CAGR) from 2018 to 2024

 

Market Outline: Vitrectomy Machines Market

The vitrectomy is a surgical procedure that is carried out by the specialist where the vitreous humor is located in order to provide a better access to the retina. This booklet describes various types of repairs such as the treatment of macular holes, removal of scar tissue, and repair of retinal detachments. In order to help retina hold in position after surgery, gas bubble or silicon oil, saline are injected.

 

Market Dynamics: Vitrectomy Machines Market

Increase in the prevalence of eye diseases in the geriatric population are majorly driving the growth of the vitrectomy machines market. The advancements in the technology is thus playing a significant role in the growth of the market. The growing awareness among the patient population is the adoption of new surgical procedures. However, the high cost of the surgical process, the lack of government support to the non-profitable organizations and poor healthcare policies in developing countries may be hindered by the growth of the vitrectomy machines market.

 

Free sample of this report is available upon request @

https://www.precisionbusinessinsights.com/market-reports/vitrectomy-machines-market/#ulp-4H8Z4LpNMLEuOnnx

 

Market Scope: Vitrectomy Machines Market

Vitrectomy machines market is segmented based on product type, applications, and end user.

Based on the product type, the market is segmented into the following:

  • Vitrectomy Machines
  • Vitrectomy Packs
  • Microscopic Illumination Equipment
  • Surgical Instruments
  • Others

Based on the applications, the market is segmented into the following:

  • Retinal detachment
  • Diabetic retinopathy
  • trauma
  • Macular Surgery
  • Pediatric Retinal Disorders
  • Others

Based on the end user, the market is segmented into the following:

  • Hospitals
  • Eye Clinics
  • Others

 

Free TOC of this report is available upon request @

https://www.precisionbusinessinsights.com/market-reports/vitrectomy-machines-market/#ulp-c654SbFYO64MsOhu

 

Regional Analysis: Vitrectomy Machines Market

Geographically, Global Vitrectomy Machinery is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. North America vitrectomy machines market driven by increase in the prevalence of eye diseases. Fraternity in the region is driving the market. Followed by North America is the European and Asia Pacific regions are dominating the market.

 

Competition Assessment: Vitrectomy Machines Market

Some of the players in the global vitrectomy machine market include:

  • IRIDEX Corporation (US)
  • Synergetics, Inc. (US)
  • Bausch & Lomb (US)
  • Optos PLC (UK)
  • Topcon Corporation (Japan)
  • Leica Microsystems GmbH (Germany)
  • Carl Zeiss Meditec AG (Germany)
  • Alcon, Inc. (US)

 

Ask Analyst for Full Information about this report @

https://www.precisionbusinessinsights.com/market-reports/vitrectomy-machines-market/#ulp-14mlyhjMGhVjZqa3

 

Notable Market Developments: Vitrectomy Machines Market

  • In August 2017, Bausch + Lomb has launched the Stellaris Elite vision enhancement system for retinal surgery in the US

 

Get access to full summary @

https://www.precisionbusinessinsights.com/market-reports/vitrectomy-machines-market/

 

About Precision Business Insights

Precision Business Insights is one of the leading market research and business consulting firms, which follows a holistic approach to solve the needs of the clients. We adopt and implement proven research methodologies to achieve better results. We help our clients by providing actionable insights and making better decisions. We provide consulting, syndicated and customized market research services based on our client needs.

Contact to Precision Business Insights,

Kemp House,

152 – 160 City Road,

London EC1V 2NX

Email: sales@precisionbusinessinsights.com

Toll Free (US): 1-866-598-1553

Website @ https://www.precisionbusinessinsights.co m

Aktuelle Nachrichten Gesundheit/Medizin Internationales Marketing/Werbung Mode/Lifestyle

Global Wearable Insulin Devices Market Size, Dynamics, Regional Share, Trends, Competitor Analysis 2013-2017 and Forecast 2018-2024

Global Wearable Insulin Devices Market: By Product Type (Patches and Pods), By Age Group (Adults and Pediatrics), By Distribution Channel (Hospital Pharmacies, Online Pharmacies, and Others), and Geography – Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2013-2017 and Forecast 2018-2024

 

Global wearable insulin devices market was valued at US$ XX Mn in 2017 and expected to grow at XX% Compound Annual Growth Rate (CAGR) from 2018 to 2024

 

Market Outline: Wearable Insulin Devices Market

Wearable insulin devices are the medical devices that helps in controlling or maintaining the blood glucose in the patient’s body. The insulin is the major part in the treatment of diabetes. Insulin is the hormone made by the pancreas which allows the body to use or store the sugar or the glucose from carbohydrates form the food. It allows to maintain the blood sugar level form either getting too high, which would result in hyperglycemia or from getting too low which would result in hypoglycemia.

 

Market Dynamics: Wearable Insulin Devices Market

Increase in the prevalence of diabetes is the major factor anticipated to drive the growth of wearable insulin devices market. Increasing health issues such as obesity and launch technologically advanced devices anticipated to fuel the growth of wearable insulin devices market. The rising awareness among the patient population with regard to advanced treatment options and increasing healthcare expenditure are expected to boost the wearable insulin devices market. The adoption of the self-care diabetes management methods and increasing R&D activities are providing opportunity to the manufacturers to further expansion of the market. However, the high cost of the device may hamper the growth of the wearable insulin devices market.

 

Free sample of this report is available upon request @

https://www.precisionbusinessinsights.com/market-reports/wearable-insulin-devices-market/#ulp-4H8Z4LpNMLEuOnnx

 

Market Scope: Wearable Insulin Devices Market

Wearable insulin devices market is segmented based on the product type, age group, and distribution channel

Based on the product type, the market is segmented into the following:

  • Patches
  • Pods

Based on the age group, the market is segmented into the following:

  • Adults
  • Pediatrics

Based on the distribution channel, the market is segmented into the following:

  • Hospital Pharmacies
  • Online Pharmacies
  • Others

 

Free TOC of this report is available upon request @

https://www.precisionbusinessinsights.com/market-reports/wearable-insulin-devices-market/#ulp-c654SbFYO64MsOhu

 

Regional Analysis:  Wearable Insulin Devices Market

Geographically, global wearable insulin devices market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. North America wearable insulin devices market is dominant when compared with that of the other regional markets owing to favorable reimbursement policies and increase in the prevalence of diabetes and obesity. According to the Centers for Disease Control and Prevention (CDC) in the year of 2016, there were 29 million patients in U.S. who are still suffering with diabetes, of which 21.0 million patients were diagnosed and 8.1 million patients are undiagnosed. The increasing awareness about the self-treatment procedures is also enhancing the growth of the wearable insulin devices market. The Asia Pacific is the region expected to offer lucrative growth opportunities owing to large untapped market and availability of large diabetic patient pool in India and China.

 

Ask Analyst for Full Information about this report @

https://www.precisionbusinessinsights.com/market-reports/wearable-insulin-devices-market/#ulp-14mlyhjMGhVjZqa3

 

Competition Assessment: Wearable Insulin Devices Market

Some of the players in the global wearable insulin devices market include:

  • Omnipod (U.S)
  • Valeritas, Inc. (U.S)
  • CeQur (Switzerland)
  • Prometheon Pharma (U.S)
  • Sproutel (U.S)
  • MedicSen (Spain)

 

Notable Market Developments: Wearable Insulin Devices Market

  • In January 2018, Valeritas launches V-Go wearable insulin delivery device in Puerto Rico.

 

Get access to full summary @

https://www.precisionbusinessinsights.com/market-reports/wearable-insulin-devices-market/

 

About Precision Business Insights

Precision Business Insights is one of the leading market research and business consulting firm, which follow a holistic approach to solve needs of the clients. We adopt and implement proven research methodologies to achieve better results. We help our clients by providing actionable insights and strategies to make better decisions. We provide consulting, syndicated and customised market research services based on our client needs.

Contact to Precision Business Insights,

Kemp House,

152 – 160 City Road,

London EC1V 2NX

Email: sales@precisionbusinessinsights.com

Toll Free (US):+1-866-598-1553

Website @https://www.precisionbusinessinsights.com